中华核医学杂志
中華覈醫學雜誌
중화핵의학잡지
CHINESE JOURNAL OF NUCLEAR MEDICINE
2008年
4期
227-230
,共4页
张锦明%田嘉禾%姚树林%丁为民%尹大一%刘伯里
張錦明%田嘉禾%姚樹林%丁為民%尹大一%劉伯裏
장금명%전가화%요수림%정위민%윤대일%류백리
雷氯必利%同位素标记%碳放射性同位素%受体,多巴胺%动物,实验
雷氯必利%同位素標記%碳放射性同位素%受體,多巴胺%動物,實驗
뢰록필리%동위소표기%탄방사성동위소%수체,다파알%동물,실험
Raclopride%Isotope labeling%Carbon radioisotopes%Receptors,dopamine%Animals,laboratory
目的 建立快速制备11C-雷氯必利(Raclopride)的方法,并对其进行生物学评价.方法 采用固相萃取法制备11C-Raclopride,即用11C-三氟甲基磺酰基甲烷(CH3-Triflate)与去甲基(Nor)-Raclopride反应得粗产品,用水稀释粗产品,将其转移到Sep-Pak C18反相柱,冲洗反相柱,再用乙醇淋洗得11C-Raclopride.研究正常SD大鼠体内11C-Raclopride分布,并行阻断剂(螺环哌啶酮)阻断后显像.制备食蟹猴帕金森病(PD)模型,行PET显像.结果 11C-Raclopride放化纯>95%,比活度>8 GBq/μmol,合成效率为60%,从11CO2到11C-Raclopride的合成时间为16 min.大鼠注射11C-Raclo pride 30 min后纹状体/小脑、纹状体/额叶皮质放射性摄取比值分别为4.67和6.20.Raclopride和螺环哌啶酮明显阻断了纹状体摄取11C-Raclopride,而Nor-Raclopride则不明显.PD模型猴11C-Raclo-pride PET显像示实验侧放射性高于对侧,出现D2受体上调.结论 固相萃取法制备11C-Raclopride速度快,放化纯高.动物显像表明11C-Raclopride能满足临床需求.
目的 建立快速製備11C-雷氯必利(Raclopride)的方法,併對其進行生物學評價.方法 採用固相萃取法製備11C-Raclopride,即用11C-三氟甲基磺酰基甲烷(CH3-Triflate)與去甲基(Nor)-Raclopride反應得粗產品,用水稀釋粗產品,將其轉移到Sep-Pak C18反相柱,遲洗反相柱,再用乙醇淋洗得11C-Raclopride.研究正常SD大鼠體內11C-Raclopride分佈,併行阻斷劑(螺環哌啶酮)阻斷後顯像.製備食蟹猴帕金森病(PD)模型,行PET顯像.結果 11C-Raclopride放化純>95%,比活度>8 GBq/μmol,閤成效率為60%,從11CO2到11C-Raclopride的閤成時間為16 min.大鼠註射11C-Raclo pride 30 min後紋狀體/小腦、紋狀體/額葉皮質放射性攝取比值分彆為4.67和6.20.Raclopride和螺環哌啶酮明顯阻斷瞭紋狀體攝取11C-Raclopride,而Nor-Raclopride則不明顯.PD模型猴11C-Raclo-pride PET顯像示實驗側放射性高于對側,齣現D2受體上調.結論 固相萃取法製備11C-Raclopride速度快,放化純高.動物顯像錶明11C-Raclopride能滿足臨床需求.
목적 건립쾌속제비11C-뢰록필리(Raclopride)적방법,병대기진행생물학평개.방법 채용고상췌취법제비11C-Raclopride,즉용11C-삼불갑기광선기갑완(CH3-Triflate)여거갑기(Nor)-Raclopride반응득조산품,용수희석조산품,장기전이도Sep-Pak C18반상주,충세반상주,재용을순림세득11C-Raclopride.연구정상SD대서체내11C-Raclopride분포,병행조단제(라배고정동)조단후현상.제비식해후파금삼병(PD)모형,행PET현상.결과 11C-Raclopride방화순>95%,비활도>8 GBq/μmol,합성효솔위60%,종11CO2도11C-Raclopride적합성시간위16 min.대서주사11C-Raclo pride 30 min후문상체/소뇌、문상체/액협피질방사성섭취비치분별위4.67화6.20.Raclopride화라배고정동명현조단료문상체섭취11C-Raclopride,이Nor-Raclopride칙불명현.PD모형후11C-Raclo-pride PET현상시실험측방사성고우대측,출현D2수체상조.결론 고상췌취법제비11C-Raclopride속도쾌,방화순고.동물현상표명11C-Raclopride능만족림상수구.
Objective 11C-Raclopride is a type-2 dopamine receptor(D2R)binding agent used in the study of Parkinson's disease.This study introduced a fast and convenient method for preparation of 11C-Raclopride and reported on the preclinical trial of this receptor tracer on animal studies.Methods 11C-Raclopride was synthesized via reaction of 11C-CH3-Triflate with Nor-Raclopride.The mixture of primary product was water-diluted and loaded on Sep-Pak C18 column for separation.The final product,11C-Raclo-pride,Was purified by column chromatography and then eluted from the C18 column with ethanol.The bio-distribution was studied in SD rats and the in vivo imaging pattern was studied in hem ipark insonjan mon-keys.Results Within 16 min from beginning of processing with 11CO2,the synthetic yield of 11C-Raclo-pride WaS 60%,radiochemical purity(RCP)>95% and specific activity 8 GBq/mmol.The uptake ratios of striatum to cerebellum and cerebral cortex were 4.67 and 6.20,respectively,at 30 min after 11C-Raclo-pride administration.The striatal uptake in normal rat brain could be blocked by N-methylspiperone(NMSP)and raclopride,but not by Nor-raclopride.PET imaging showed higher striatal D2 R uptake on the D2 receptor up-regulated side of the experimental monkeys relative to the contralateral side.Conclusions Column chromatography for purification of 11C-Raclopride Was fast,convenient and with a RCP similar to that of high performance liquid chromatography purification.Preliminary PET findings using animal model suggested that 11C-Raclopride by column chromatogram purification might be considered for clinical use.